Overwieght. Obesity and other hyperalimentation
Conditions
Interventions
Intervention 1: First group: Control: Venustat: 120 mg cap: 3 cap per day for three months + Standard diet Classical Medicine for three months. (The calorie consumption is equivalent in three group
Treatment - Drugs
First group: Control: Venustat: 120 mg cap: 3 cap per day for three months + Standard diet Classical Medicine for three months. (The calorie consumption is equivalent in three groups.)
Group 3: Second Intervention: Traditional Persian Medicine model: Traditional Persian Medicine diet. (The calorie consumption is equivalant in three groups.) + Dava Balgham. (Medicinal product based
Group 2: First Intervention: Classical Medicine diet.(The calorie consumption is equivalant in three groups) + Dava balgham (Medicinal product based on zattaria multiflora and Nigella sativa and Masti
Sponsors
Vice chancellor for research, Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
77 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : ?Age 18 to 60 years? BMI 27 to 29/9 (Kg / m2)? Waist circumference greater than 88 cm - Exclusion criteria : Patients with diabetes and high blood pressure to used medicine? Chronic diseases of the liver? Chronic failure of kidney? Heavy smoker more than 20 cigarettes per day? Obesity caused by metabolic disorders? Familial obesity? Pregnancy? Lactation? AIDS and Hepatitis? Cancer? Obese patients referred to clinics in the last 6 months? Patients with body composition fat and water lesser than muscle based on Bioelectrical impedance analyzer? A history of intolerance or allergy to honey, thyme, mastic , capticum and Nigella sativa .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body max Index. Timepoint: Before intervention then every two weeks until the end of the intervention. Method of measurement: By (Body Composition Analyzer System) model Tanita.;Body Composition. Timepoint: Before intervention and three months after intervention. Method of measurement: Body Composition Analyzer System model tanita.;Basal Metabolism Rate. Timepoint: Before intervention and three months after intervention. Method of measurement: By Indirect calorimetry SET?. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fast LDL. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum LDL concentration in mg/dl.;Fast HDL. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum HDL concentration in mg/dl.;Fast Blood sugar. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum sugar concentration in mg/dl.;Fast Cholesterol. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum Cholesterol concentration in mg/dl.;Fast TG. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum TG concentration in mg/dl.;Fast SGOT? SGPT? ALKP. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum SGOT .SGPT .ALKP concentration in unit/lit.;Thyroid hormones (T3 .T4 .TSH). Timepoint: Before intervention and three months after intervention. Method of measurement: Serum Thyroid hormones concentration in ng/ml.;Fe serum concentration. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum Fe concentration in micg/dl.;Zn serum concentraiton. Timepoint: Before intervention and three months after intervention. Method of measurement: Fasting serum Zn concentration in micg/dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLiely Hamidnia
School of Persian and Complementary medicine of Mashhad
Outcome results
None listed